Back to School: How biopharma can reboot drug development. Access exclusive analysis here

U.K. committee issues NICE report

The U.K. House of Commons' Health Select Committee issued a report on Thursday recommending that the National Institute for Health and Clinical Excellence (NICE) initially assess all new drugs via a "shorter, less in-depth initial evaluation." The proposed

Read the full 380 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE